CVM Short Volume
CEL-SCI Corporation (CVM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $7.9M, listed on AMEX, employing roughly 43 people, carrying a beta of 0.65 to the broader market. CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Led by Geert R. Kersten, public since 1983-12-08.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-07-16
- Short Volume
- 814.5K
- Total Volume
- 1.1M
- Short %
- 76.72%
- 30-Day Avg Short %
- 44.32%
Showing 30 days of FINRA short volume data for CEL-SCI Corporation.
Learn how short volume is reported and how to read the data →
Frequently asked CVM short volume questions
- What is the daily CVM short volume?
- As of Jul 16, 2026, CEL-SCI Corporation (CVM) short volume is 814.5K shares against 1.1M total reported volume, or 76.72% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is CVM short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does CVM short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.